Medical Toxicology

This programme is available to those who have already completed our PgDip in Medical Toxicology.

This MSc in Medical Toxicology is a part-time distance learning course for medical personnel. It is particularly designed for clinical pharmacologists in training, specialist trainees in accident and emergency medicine or acute medicine and other disciplines, and those intending to enter or already working in the pharmaceutical industry.

It is also designed for those working in poisons centres, for health professionals, including hospital and community pharmacists and for those with a degree in Life Sciences or other individuals seeking a career in the government regulatory bodies or the pharmaceutical or chemical industry.

The course is available to a selected number of candidates, who have successfully completed our postgraduate diploma in Medical Toxicology to an acceptable standard.

The course aims to:

• Introduce you to the broad principles underlying medical toxicology.
• seek to integrate an understanding of the mechanisms by which drugs and other chemicals produce toxic effects and how these can be predicted, treated and whenever possible, prevented.

A key aim of the teaching programme is to encourage critical thinking, as we aim to equip you with practical and factual knowledge and also provide a basic approach to toxicological problems, encouraging attitudes and abilities which will be of lasting value in the future.

Distinctive features

The distance learning format helps candidates to complete requirements in their own time. The topic usually depends on the local workplace and relates to the improvement of existing services.

We're committed to delivering programmes that are innovative and relevant, providing the best learning outcomes and career prospects for our students. In light of this, we're currently reviewing some elements of this programme. As such, the details shown are subject to change and indicative only. You can still apply now. We'll update this page and contact all offer holders when the review is complete to confirm any changes.